Zalewska-Kaszubska Jadwiga
Zakładu Farmakodynamiki, Katedry Farmakologii Akademii Medycznej w Łodzi.
Neurol Neurochir Pol. 2002 Mar-Apr;36(2):329-36.
Adenosine is known to play a significant role as modulator of neuronal activity. Extracellular levels of adenosine increase during ischaemia. Adenosine has been reported to have beneficial effects against neurodegenerative diseases, although the mechanisms are not fully clarified. Adenosine A1 receptors are found on neurons and presumably involved in the regulation of the release of excitatory amino acids. Using adenosine kinase inhibitors and novel A1 agonists with potent CNS effects and diminished influence on the cardiovascular system offers therapeutic potential to the treatment of neurodegenerative brain disorders. Recently deleterious effects have been reported following the activation of A2A and A3 adenosine receptor subtypes. The selective A2A receptor antagonists have been demonstrated to markedly reduce cell death after brain ischaemia in the rat. This paper discusses the possible role of adenosine receptor subtypes and their agonists or antagonists in neurodegenerative diseases treatment.
已知腺苷作为神经元活动的调节剂发挥着重要作用。缺血期间细胞外腺苷水平会升高。据报道,腺苷对神经退行性疾病具有有益作用,尽管其机制尚未完全阐明。腺苷A1受体存在于神经元上,可能参与兴奋性氨基酸释放的调节。使用腺苷激酶抑制剂和对中枢神经系统有强效作用且对心血管系统影响较小的新型A1激动剂为神经退行性脑疾病的治疗提供了潜在的治疗方法。最近有报道称,A2A和A3腺苷受体亚型激活后会产生有害影响。已证明选择性A2A受体拮抗剂可显著减少大鼠脑缺血后的细胞死亡。本文讨论了腺苷受体亚型及其激动剂或拮抗剂在神经退行性疾病治疗中的可能作用。